News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center
Logo of MD Anderson Cancer Center from X
Oct 24, 2023, 13:44

MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone – MD Anderson Cancer Center

Quoting

“MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone.

“These findings showcase, for the first time, the potential of combining immunotherapy with a PARP inhibitor to deliver significant clinical improvements for these patients,” says lead investigator Shannon Westin.”

For more details click here.
cancer Endometrial cancer Headlines MD Anderson Cancer Center OncoDaily Oncology Shannon Westin
Special Coverage
Blog
May 9, 2025, 20:14
Catherine Alix-Panabières: Amazing 3rd General Assembly of the European GUIDE.MRD IHI Project
Blog
May 9, 2025, 19:44
Amanda Impellizzeri: MCED Act Just Hit a Historic Milestone
Blog
May 9, 2025, 19:25
Sondus Alsharidah: Building Bridges in Pediatric Oncology and Oncology Care
Blog
May 9, 2025, 19:03
Rasha Aboelhassan: Have you ever felt like everything is going so smoothly, and your dreams are coming true?
Blog
May 9, 2025, 18:51
Emma Walmsley: GSK Medics Are Accelerating the Partnerships We Need
Insight
May 9, 2025, 18:09
Katsuaki Maehara Highlights TIM-3 as a Potential Target for Lung Adenocarcinoma Precancer Interception
Societies
May 9, 2025, 18:03
Who From Oncology is Featured in TIME100 Health 2025?
Blog
May 9, 2025, 17:53
Jill Barnholtz-Sloan: It Takes Everyone on the Team to Fulfill the Mission of the NCI to End Cancer
Blog
May 9, 2025, 17:45
AstraZeneca Unveils $300M Cell Therapy Facility in Rockville to Boost CAR-T Cell Therapy Production
Blog
May 9, 2025, 17:38
Matthew Mifsud Highlights USF ENT and TGH Cancer Institute 2025 Head and Neck Cancer Symposium
Blog
May 9, 2025, 17:23
Jan-Henning Klusmann: RNA Innovation in Focus – Retreat of the DFG Research Unit RU5433
Insight
May 9, 2025, 17:19
Bishal Gyawali: I Hope Trial Sponsors and Trialists Will Find These Results Helpful and Meaningful